Evidence map›Paper›PMID 31084338›Full record

ArticleStroke2019

Overlap in the Genetic Architecture of Stroke Risk, Early Neurological Changes, and Cardiovascular Risk Factors.

Laura Ibanez, Laura Heitsch, Umber Dube, Fabiana H G Farias, John Budde, Kristy Bergmann, Rich Davenport, Joseph Bradley, Caty Carrera, Janne Kinnunen and 7 more

Open access · greenAbstract read
In one paragraph

Article in Stroke, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 4 countries.

Laura IbanezFrom the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.
Laura HeitschDivision of Emergency Medicine (L.H.), Washington University School of Medicine, St. Louis, MO.
Umber DubeFrom the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.
Fabiana H G FariasFrom the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.
John BuddeFrom the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.
Kristy BergmannFrom the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.
Rich DavenportFrom the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.
Joseph BradleyFrom the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.
Caty CarreraNeurovascular Research Laboratory, Vall d'Hebron Institute of Research, Barcelona, Spain (C. Carrera, I.F.-C., J.M.).
Janne KinnunenDepartment of Neurology, Helsinki University Hospital, Finland (J.K., H.S., D.S.).
Hanne SallinenDepartment of Neurology, Helsinki University Hospital, Finland (J.K., H.S., D.S.).
Daniel StrbianDepartment of Neurology, Helsinki University Hospital, Finland (J.K., H.S., D.S.).
Agnieszka SlowikDepartment of Neurology, Jagiellonian University Medical College, Kraków, Poland (A.S.).
Israel Fernandez-CadenasNeurovascular Research Laboratory, Vall d'Hebron Institute of Research, Barcelona, Spain (C. Carrera, I.F.-C., J.M.).
Joan MontanerNeurovascular Research Laboratory, Vall d'Hebron Institute of Research, Barcelona, Spain (C. Carrera, I.F.-C., J.M.).
Jin-Moo LeeDepartment of Neurology (L.H., J.-M.L.), Washington University School of Medicine, St. Louis, MO.
Carlos CruchagaFrom the Department of Psychiatry (L.I., U.D., F.H.G.F., J. Budde, K.B., R.D., J. Bradley, C. Cruchaga), Washington University School of Medicine, St. Louis, MO.
Washington University in St. Louis · USHelsinki University Hospital · FIVall d'Hebron Institut de Recerca · ESConsejo Superior de Investigaciones Científicas · ESDavenport University · USJagiellonian University · PL

Funding

Genetic Architecture of Acute Human Brain IschemiaR01NS085419 · NINDS · WASHINGTON UNIVERSITY · PI CRUCHAGA, CARLOS, LEE, JIN-MOO · 2014 to 2018
$2.8M
Mid-America Regional Coordinating Center (MARCC)U24NS107230 · NINDS · WASHINGTON UNIVERSITY · PI Andria Lee Ford, Peter David Panagos · 2018 to 2026
$2.8M
GENETICS OF EARLY NEUROLOGICAL INSTABILITY AFTER ISCHEMIC STROKE (GENISIS)K23NS099487 · NINDS · WASHINGTON UNIVERSITY · PI HEITSCH, LAURA · 2017 to 2021
$996k
NINDS NIH HHS K23 NS099487NINDS NIH HHS R01 NS085419NINDS NIH HHS U24 NS107230
6 · The paper itself

Abstract

Background and Purpose- The genetic relationships between stroke risk, stroke severity, and early neurological changes are complex and not completely understood. Genetic studies have identified 32 all stroke risk loci. Polygenic risk scores can be used to compare the genetic architecture of related traits. In this study, we compare the genetic architecture of stroke risk, stroke severity, and early neurological changes with that of 2 stroke risk factors: type 2 diabetes mellitus (T2DM) and hypertension. Methods- We assessed the degree of overlap in the genetic architecture of stroke risk, T2DM, hypertension, and 2 acute stroke phenotypes based on the National Institutes of Health Stroke Scale (NIHSS), which ranges from 0 for no stroke symptoms to 21 to 42 for a severe stroke: baseline (within 6 hours after onset) and change in NIHSS (ΔNIHSS=NIHSS at baseline-NIHSS at 24 hours). This was done by (1) single-nucleotide polymorphism by single-nucleotide polymorphism comparison, (2) weighted polygenic risk scores with sentinel variants, and (3) whole-genome polygenic risk scores using multiple P thresholds. Results- We found evidence of genetic architecture overlap between stroke risk and T2DM ( P=2.53×10

Indexed as

Databases, GeneticMultifactorial InheritancePolymorphism, Single NucleotideAgedDiabetes Mellitus, Type 2FemaleHumansHypertensionMaleMiddle AgedRisk FactorsStrokediabetes mellitusgeneticshypertensionrisk factorsstroke

Identifiers

PMID31084338
PMCPMC6538457
OpenAlexW2945027013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.